Reactive stroma in prostate cancer progression

被引:390
作者
Tuxhorn, JA [1 ]
Ayala, GE
Rowley, DR
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
关键词
prostate; prostatic neoplasms; growth substances; granulation tissue; extracellular matrix;
D O I
10.1016/S0022-5347(05)65620-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The development of an altered stromal microenvironment in response to carcinoma is a common feature of many tumors. We reviewed the literature describing characteristics of reactive stroma, how reactive stroma affects cancer progression and how carcinoma regulates reactive stroma. Moreover, we present a hypothesis of reactive stroma in prostate cancer and discuss how the biology of reactive stroma may be used in novel diagnostic and therapeutic approaches. Materials and Methods: An extensive literature search was performed to review reports of the general features of wound repair stroma, general stromal responses to carcinoma, and stromal biology of normal and prostate cancer tissues. These studies were analyzed and a reactive stroma hypothesis in prostate cancer was developed. Results: Modifications to the stroma of breast, colon and prostate tumors parallel the generation of granulation tissue in wound repair. These changes include stromal cell phenotypic switching, extracellular matrix remodeling and angiogenesis induction. Therefore, it is predicted that a modified wound healing response induces the formation of reactive stroma in cancer to create a tumor promoting environment. Based on its role in wound repair and its over expression in prostate cancer, transforming growth factor-beta stands out as a potential regulator of reactive stroma. Conclusions: Reactive stroma in prostate cancer and granulation tissue in wound repair show similar biological responses and processes that are predicted to promote cancer progression. Further identification of specific functional and regulatory mechanisms in prostate cancer reactive stroma may aid in the use of reactive stroma for novel diagnostic and therapeutic approaches.
引用
收藏
页码:2472 / 2483
页数:12
相关论文
共 135 条
  • [1] Tissue factor expression and angiogenesis in human prostate carcinoma
    Abdulkadir, SA
    Carvalhal, GF
    Kaleem, Z
    Kisiel, W
    Humphrey, PA
    Catalona, WJ
    Milbrandt, J
    [J]. HUMAN PATHOLOGY, 2000, 31 (04) : 443 - 447
  • [2] Fibronectin in human prostatic cells in vivo and in vitro:: expression, distribution, and pathological significance
    Albrecht, M
    Renneberg, H
    Wennemuth, G
    Möschler, O
    Janssen, M
    Aumüller, G
    Konrad, L
    [J]. HISTOCHEMISTRY AND CELL BIOLOGY, 1999, 112 (01) : 51 - 61
  • [3] Balbay MD, 1999, CLIN CANCER RES, V5, P783
  • [4] Borgström P, 1998, PROSTATE, V35, P1
  • [5] TRANSFORMING GROWTH-FACTOR-BETA REGULATES THE SPLICING PATTERN OF FIBRONECTIN MESSENGER-RNA PRECURSOR
    BORSI, L
    CASTELLANI, P
    RISSO, AM
    LEPRINI, A
    ZARDI, L
    [J]. FEBS LETTERS, 1990, 261 (01) : 175 - 178
  • [6] EXPRESSION OF DIFFERENT TENASCIN ISOFORMS IN NORMAL, HYPERPLASTIC AND NEOPLASTIC HUMAN BREAST TISSUES
    BORSI, L
    CARNEMOLLA, B
    NICOLO, G
    SPINA, B
    TANARA, G
    ZARDI, L
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) : 688 - 692
  • [7] INDIRECT ANGIOGENIC CYTOKINES UP-REGULATE VEGF AND BFGF GENE-EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS, WHEREAS HYPOXIA UP-REGULATES VEGF EXPRESSION ONLY
    BROGI, E
    WU, TG
    NAMIKI, A
    ISNER, JM
    [J]. CIRCULATION, 1994, 90 (02) : 649 - 652
  • [8] Brown LF, 1999, CLIN CANCER RES, V5, P1041
  • [9] BROWN LF, 1993, AM J PATHOL, V142, P793
  • [10] CHIQUETEHRISMANN R, 1989, CANCER RES, V49, P4322